Moreover, the lncRNA MALAT1 could mediate cisplatin resistance via the miR-101-3p/VEGF-C pathway in bladder cancer (Liu et al., 2019) and promote cell proliferation and inhibit apoptosis by sponging miR-101 in colorectal cancer (Si et al., 2019). Here, VEGFC is linked to urinary bladder cancer.